The first rotavirus vaccine and the politics of acceptable risk

Milbank Quarterly

Volumn 90, Issue 2, 2012, Pages 278-310

  Schwartz, Jason L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Intussusception; Policymaking; Risk; Rotavirus vaccines; Safety; Vaccination

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; ROTAVIRUS VACCINE;

AUTISM; DECISION MAKING; DEVELOPING COUNTRY; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; INTUSSUSCEPTION; PERCEPTION; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PUBLICATION; REVIEW; RISK FACTOR; SEMI STRUCTURED INTERVIEW; VACCINATION; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; HEALTH POLICY; HUMANS; INTUSSUSCEPTION; POLICY MAKING; POLITICS; RISK ASSESSMENT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES;

EID: 84862520547     PISSN: 0887378X     EISSN: 14680009     Source Type: Journal    
DOI: 10.1111/j.1468-0009.2012.00664.x     Document Type: Review

References (100)

1. Abramson, J., and, L. Pickering,. 2002. US Immunization Policy. JAMA 287 (4): 505-9. (Pubitemid 34251991)
2. Allen, A., 2007. Vaccine. New York: Norton.
3. Altman, L., 1999a. In Turnabout, Federal Panel Votes against a Vaccine. New York Times, October 23.
4. Altman, L., 1999b. Vaccine for Infant Diarrhea Is Withdrawn as Health Risk. New York Times, October 16.
5. AHP (American Home Products) Corporation. 1999. Annual Report 1998.
6. American Academy of Pediatrics. 2010. Brief Amici Curiae of the American Academy of Pediatrics and 21 Other Physician and Public Health Organizations in Support of Respondent. Bruesewitz v. Wyeth, 562 U.S. (2011). Available at (accessed February 24, 2011).
7. Aronowitz, R., 1998. Making Sense of Illness: Science, Society, and Disease. Cambridge: Cambridge University Press.
8. Bines, J., 2006. Intussusception and Rotavirus Vaccines. Vaccine 24: 3772-76.
9. Brief for the United States as Amicus Curiae Supporting Respondents. 2010. Bruesewitz v. Wyeth, 562 U.S. (2011).
10. Bruesewitz v. Wyeth, 562 U.S. (2011).
11. CDC (Centers for Disease Control and Prevention). 1998a. Advisory Committee on Immunization Practices Meeting. Transcript, February 11-12.
12. CDC (Centers for Disease Control and Prevention). 1998b. Advisory Committee on Immunization Practices Meeting. Transcript, June 24-25.
13. CDC (Centers for Disease Control and Prevention). 1999a. Advisory Committee on Immunization Practices Meeting. Transcript, February 18.
14. CDC (Centers for Disease Control and Prevention). 1999b. Advisory Committee on Immunization Practices Meeting. Transcript, June 17.
15. CDC (Centers for Disease Control and Prevention). 1999c. Advisory Committee on Immunization Practices Meeting. Transcript, October 22.
16. CDC (Centers for Disease Control and Prevention). 1999d. Intussusception among Recipients of Rotavirus Vaccine-United States, 1998-1999. MMWR Morbidity and Mortality Weekly Report 48 (27): 577-81.
17. CDC (Centers for Disease Control and Prevention). 1999e. Rotavirus Vaccine for the Prevention of Rotavirus Gastroenteritis among Children-Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 48 (RR-2).
18. CDC (Centers for Disease Control and Prevention). 1999f. Withdrawal of Rotavirus Vaccine Recommendation. MMWR Morbidity and Mortality Weekly Report 48 (43): 1007.
19. CDC (Centers for Disease Control and Prevention). 2000. Advisory Committee on Immunization Practices Meeting. Minutes, June 22.
20. CDC (Centers for Disease Control and Prevention). 2004. Suspension of Rotavirus Vaccine after Reports of Intussusception-United States, 1999. MMWR Morbidity and Mortality Weekly Report 53 (34): 786-89.
21. CDC (Centers for Disease Control and Prevention). 2011. Statement regarding Rotarix and RotaTeq Rotavirus Vaccines and Intussusception. Available at (accessed August 11, 2011).
22. Clark, H., P. Offit, U. Parashar, and, R. Ward,. 2008. Rotavirus Vaccines. In Vaccines, 5th ed., ed., S. Plotkin, W. Orenstein, and, P. Offit, 715-34. Philadelphia: Saunders.
23. Coffin, S., and, R. Nelson,. 2005. Optimizing Risks and Benefits: The Case of Rotavirus Vaccine. In Ethics and Research with Children: A Case-Based Approach, ed., E. Kodish, 46-62. Oxford: Oxford University Press.
24. Cohen, J., 2001. Rethinking a Vaccine's Risk. Science 293: 1576-77. (Pubitemid 32807806)
25. Colgrove, J., 2006. State of Immunity: The Politics of Vaccination in Twentieth-Century America. Berkeley: University of California Press / New York: Milbank Memorial Fund.
26. Colgrove, J., and, R. Bayer,. 2005. Could It Happen Here? Vaccine Risk Controversies and the Specter of Derailment. Health Affairs 24 (3): 729-39.
27. Cross, F.B., 1994. The Public Role in Risk Control. Environmental Law 24: 887-969.
28. Curns, A.T., C.A. Steiner, M. Barrett, K. Hunter, E. Wilson, and, U.D. Parashar,. 2010. Reduction in Acute Gastroenteritis Hospitalizations among US Children after Introduction of Rotavirus Vaccine: Analysis of Hospital Discharge Data from 18 US States. Journal of Infectious Diseases 201 (11): 1617-24.
29. Danavaro-Holliday, M., A. Wood, and, C. LeBaron,. 2002. Rotavirus Vaccine and the News Media, 1987-2001. JAMA 287 (11): 1455-62. (Pubitemid 34250511)
30. Evans, G., E. Levine, and, A. Jacobs,. 2012. Legal Issues. In Vaccines, 6th ed., ed., S. Plotkin, W. Orenstein, and, P. Offit,. Philadelphia: Saunders, forthcoming.
31. FDA (Food and Drug Administration). 1997. Vaccines and Related Biological Products Advisory Committee Meeting. Transcript, December 12.
32. FDA (Food and Drug Administration). 1998a. Approval Letter from FDA Center for Biologics Evaluation and Research to Wyeth Laboratories, August 31.
33. FDA (Food and Drug Administration). 1998b. New Oral Rotavirus Vaccine Helps Prevent Childhood Diarrhea and Vomiting. Press Release, August 31.
34. FDA (Food and Drug Administration). 1999. Vaccines and Related Biological Products Advisory Committee Meeting. Transcript, September 14.
35. Fischhoff, B., S. Lichtenstein, P. Slovic, S.L. Derby, and, R.L. Keeney,. 1981. Acceptable Risk. Cambridge: Cambridge University Press.
36. GAVI Alliance. 2000. Rotavirus Vaccines: What Next for the Countries That Need Them Most? GAVI Quarterly 5. Available at (accessed February 24, 2012).
37. Glass, R., 2010. Interview with Roger I. Glass. February 18.
38. Glass, R., J. Bresee, U. Parashar, B. Jiang, and, J. Gentsch,. 2004. The Future of Rotavirus Vaccines: A Major Setback Leads to New Opportunities. The Lancet 363: 1547-50. (Pubitemid 38596836)
39. Glass, R., P. Kilgore, R. Holman, S. Jin, J. Smith, P. Woods, M. Clarke, M. Ho, and, J. Gentsch,. 1996. The Epidemiology of Rotavirus Diarrhea in the United States: Surveillance and Estimates of Disease Burden. Journal of Infectious Diseases 174 (supp. 1): S5-S11. (Pubitemid 26293116)
40. Glass, R., M. Patel, and, U. Parashar,. 2011. Lessons from the US Rotavirus Vaccination Program. JAMA 306 (15): 1701-2.
41. Gostin, L.O., 2008. Public Health Law: Power, Duty, Restraint. 2nd ed. Berkeley: University of California Press / New York: Milbank Memorial Fund.
42. Gray, G.M., and, D.P. Ropeik,. 2002. Dealing with the Dangers of Fear: The Role of Risk Communication. Health Affairs 21 (6): 106-16.
43. Greenberg, H., 2011. Rotavirus Vaccination and Intussusception-Act II. New England Journal of Medicine 364 (24): 2354-55.
44. Greene, J., 2007. Prescribing by Numbers: Drugs and the Definition of Disease. Baltimore: Johns Hopkins University Press.
45. Griffin, M., M. Braun, and, K. Bart,. 2009. What Should an Ideal Vaccine Postlicensure Safety System Be? American Journal of Public Health 99 (S2): S345-50.
46. Gutmann, A., and, D. Thompson,. 2004. Why Deliberative Democracy? Princeton, NJ: Princeton University Press.
47. Hackam, D., T. Grikscheit, K. Wang, K. Newman, and, H. Ford,. 2010. Pediatric Surgery. In Schwartz's Principles of Surgery, 9th ed., ed., F. Brunicardi, D. Andersen, T. Billiar, D. Dunn, J. Hunter, J. Matthews, and, R. Pollock, 1409-57. New York: McGraw-Hill.
48. Harris, G., 2010. Journal Retracts 1998 Paper Linking Autism to Vaccines. New York Times, February 3.
49. IMF (International Medica Foundation). 2011. International Medica Foundation. Available at (accessed August 15, 2011).
50. Jasanoff, S., 1990a. American Exceptionalism and the Political Acknowledgement of Risk. Daedalus 119 (4): 61-81.
51. Jasanoff, S., 1990b. The Fifth Branch: Science Advisers as Policymakers. Cambridge, MA: Harvard University Press.
52. Jefferson, T., 1999. Pediatricians Alerted to Five New Vaccines. JAMA 281 (21): 1973-75. (Pubitemid 29254842)
53. Kapikian, A., 2011. History of Rotavirus Vaccines, Part I: RotaShield. In History of Vaccine Development, ed., S. Plotkin, 285-314. New York: Springer.
54. Kirby, D., 2005. Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: A Medical Controversy. New York: St. Martin's Press.
55. Koplan, J., 2009. Interview with Jeffrey P. Koplan, November 16.
56. Light, D., ed. 2010. The Risks of Prescription Drugs. New York: Columbia University Press.
57. Lowrance, W., 1976. Of Acceptable Risk: Science and the Determination of Safety. Los Altos, CA: William Kaufman.
58. Lynch, M., W. Shieh, J. Bresee, K. Tatti, J. Gentsch, T. Jones, B. Jiang, E. Hummelman, C. Zimmerman, S. Zaki, and, R. Glass,. 2006. Intussusception after Administration of the Rhesus Tetravalent Rotavirus Vaccine (Rotashield): The Search for a Pathogenic Mechanism. Pediatrics 117 (5): e827-32. (Pubitemid 46071348)
59. Marwick, C., 1998. Rotavirus Vaccine a Boon to Children. JAMA 279 (7): 489-90. (Pubitemid 28113408)
60. Matson, D., 2006. RotaShield: The Ill-Fated Rhesus-Human Reassortant Rotavirus Vaccine. Pediatric Annals 35 (1): 44-50.
61. McAbee, G., W. McDonnell, and, S. Donn,. 2011. Bruesewitz v. Wyeth: Ensuring the Availability of Children's Vaccines. Pediatrics 127 (6): 1180-81.
62. Melton, L., 2000. Lifesaving Vaccine Caught in an Ethical Minefield. The Lancet 356: 318.
63. Modlin, J., 2009. Interview with John F. Modlin, November 11.
64. Mundy, A., 2001. Dispensing with the Truth. New York: St. Martin's Press.
65. Murphy, B., D. Morens, L. Simonsen, R. Chanock, J. La Montagne, and, A. Kapikian,. 2003. Reappraisal of the Association of Intussusception with the Licensed Live Rotavirus Vaccine Challenges Initial Conclusions. Journal of Infectious Diseases 187: 1301-8. (Pubitemid 36442707)
66. Murphy, T., P. Gargiullo, M. Massoudi, D. Nelson, A. Jumaan, C. Okoro, L. Zanardi, S. Setia, E. Fair, C. LeBaron, M. Wharton, and, J. Livengood,. 2001. Intussusception among Infants Given an Oral Rotavirus Vaccine. New England Journal of Medicine 344 (8): 564-72. (Pubitemid 32167870)
67. Murphy, T., P. Smith, P. Gargiullo, and, B. Schwartz,. 2003. The First Rotavirus Vaccine and Intussusception: Epidemiological Studies and Policy Decisions. Journal of Infectious Diseases 187: 1309-13. (Pubitemid 36438971)
68. National Vaccine Information Center. 2012. National Vaccine Information Center-Vaccine Watch Dog. Available at (accessed February 24, 2012).
69. Neergaard, L., 1998. FDA Approves World's First Vaccine against Children's Diarrhea. September 1. Available at (accessed March 29, 2012).
70. Neustadt, R., and, H. Fineberg,. 1978. The Swine Flu Affair: Decision-Making on a Slippery Disease. Washington, DC: U.S. Department of Health, Education and Welfare.
71. Offit, P., 2005. The Cutter Incident. New Haven, CT: Yale University Press.
72. Offit, P., 2009. Interview with Paul A. Offit, November 30.
73. Offit, P., and, H. Clark,. 2011. Rotavirus Vaccines, Part II: Raising the Bar for Vaccine Safety Studies. In History of Vaccine Development, ed., S. Plotkin, 315-28. New York: Springer.
74. Offit, P., R. Davis, and, D. Gust,. 2008. Vaccine Safety. In Vaccines, 5th ed., ed., S. Plotkin, W. Orenstein, and, P. Offit, 1629-50. Philadelphia: Saunders.
75. Oliver, T.R., 2006. The Politics of Health Policy. Annual Review of Public Health 27: 195-233.
76. Orenstein, W., 2009. Interview with Walter A. Orenstein, November 23.
77. Patel, M., V. Lopez-Collada, M. Bulhoes, L. De Oliviera, A. Marquez, and, B. Flannery,. 2011. Intussusception Risk and Health Benefits of Rotavirus Vaccination in Mexico and Brazil. New England Journal of Medicine 364 (24): 2283-92.
78. Peter, G., and, M. Myers,. 2002. Intussusception, Rotavirus, and Oral Vaccines: Summary of a Workshop. Pediatrics 110 (6): e67-e72.
79. Porter, R., 1997. The Greatest Benefit to Mankind: A Medical History of Humanity. New York: Norton.
80. Porter, T., 1995. Trust in Numbers: The Pursuit of Objectivity in Science and Public Life. Princeton, NJ: Princeton University Press.
81. Rennels, M., U. Parashar, R. Holman, C. Le, H. Chang, and, R. Glass,. 1998. Lack of an Apparent Association between Intussusception and Wild or Vaccine Rotavirus Infection. Pediatric Infectious Disease Journal 17 (10): 924-25. (Pubitemid 28506420)
82. Roberts, L., 2004. Rotavirus Vaccines' Second Chance. Science 305: 1890-93. (Pubitemid 39287964)
83. Satcher, D., 1999. Statement by David Satcher, M.D., Surgeon General of the United States. Vaccines-Finding the Balance between Public Safety and Personal Choice. Hearing before the U.S. House of Representatives, Committee on Government Reform, August 3.
84. Schwartz, J., 2010. HPV Vaccination's Second Act: Promotion, Competition, and Compulsion. American Journal of Public Health 100 (10): 1841-44.
85. Smith, J., 2010. The Structure, Role, and Procedures of the U.S. Advisory Committee on Immunization Practices (ACIP). Vaccine 28S: A68-A75.
86. Smith, M., S. Ellenberg, L. Bell, and, D. Rubin,. 2008. Media Coverage of the Measles-Mumps-Rubella Vaccine and Autism Controversy and Its Relationship to MMR Immunization Rates in the United States. Pediatrics 121 (4): e836-43.
87. Smith, P., B. Schwartz, A. Mokdad, A. Bloch, M. McCauley, and, T. Murphy,. 2003. The First Oral Rotavirus Vaccine, 1998-1999: Estimates of Uptake from the National Immunization Survey. Public Health Reports 118 (2): 134-43. (Pubitemid 36538402)
88. Tate, J.E., A.H. Burton, C. Boschi-Pinto, A. Duncan Steele, J. Duque, and, U.D. Parashar,. 2011a. 2008 Estimate of Worldwide Rotavirus-Associated Mortality in Children Younger Than 5 Years before the Introduction of Universal Rotavirus Vaccination Programmes: A Systematic Review and Meta-Analysis. The Lancet Infectious Diseases 12 (2): 136-41.
89. Tate, J.E., M.M. Cortese, D.C. Payne, A.T. Curns, C. Yen, D.H. Esposito, J.E. Cortes, B.A. Lopman, M.M. Patel, J.R. Gentsch, and, U.D. Parashar,. 2011b. Uptake, Impact, and Effectiveness of Rotavirus Vaccination in the United States: Review of the First 3 Years of Postlicensure Data. Pediatric Infectious Disease Journal 30 (suppl. 1): S56-S60.
90. U.S. Congress. House of Representatives. Committee on Government Reform. 1999. Vaccines-Finding the Balance between Public Safety and Personal Choice, August 3.
91. U.S. Congress. House of Representatives. Committee on Government Reform. 2000. Conflicts of Interest in Vaccine Policy Making. Majority Staff Report. Available at (accessed August 10, 2011).
92. Wakefield, A., S. Murch, A. Anthony, J. Linnell, D. Casson, M. Malik, M. Berelowitz, A. Dhillon, M. Thomson, P. Harvey, A. Valentine, S. Davies, and, J. Walker-Smith,. 1998. Ileal-Lymphoid-Nodular Hyperplasia, Non-specific Colitis, and Pervasive Developmental Disorder in Children. The Lancet 351 (9103): 637-41. (Pubitemid 28098447)
93. Weijer, C., 2000. The Future of Research into Rotavirus Vaccine. BMJ 321: 525-26.
94. Wharton, M., 2000. Judgment under Uncertainty: Suspending the Use of Rotavirus Vaccine. Presentation to the 2000 Epidemic Intelligence Service conference.
95. Wharton, M., 2009. Interview with Melinda Wharton, November 24.
96. Whitford, D., 1999. AHP's Awful Losing Streak. Fortune 140 (10): 52, 56.
97. WHO (World Health Organization). 2000. Report of the Meeting on Future Directions for Rotavirus Vaccine Research in Developing Countries. Geneva.
98. WHO (World Health Organization). 2011. Rotavirus Vaccine and Intussusception: Report from an Expert Consultation. Weekly Epidemiological Record 86: 317-21.
99. Wyeth-Ayerst. 1998. RotaShield package insert.
100. Zanardi, L., P. Haber, G. Mootrey, M. Niu, and, M. Wharton,. 2001. Intussusception among Recipients of Rotavirus Vaccine: Reports to the Vaccine Adverse Event Reporting System. Pediatrics 107 (6): e97-e102.